BGN and chronic obstructive pulmonary disease: On the other hand, biglycan, which shares similar glycosaminoglycan chain composition and possibly some of decorin functions [5, 16], was not significantly different between COPD and healthy controls (supplementary table S3 and supplementary figure S2c).